Effects of Trastuzumab Emtansine (T-DM1) on QT Interval and Safety of Pertuzumab Plus T-DM1 in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer (Q39816545)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of Trastuzumab Emtansine (T-DM1) on QT Interval and Safety of Pertuzumab Plus T-DM1 in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer |
scientific article |
Statements
1 reference
Effects of Trastuzumab Emtansine (T-DM1) on QT Interval and Safety of Pertuzumab Plus T-DM1 in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer (English)
1 reference
Manish Gupta
1 reference
Bei Wang
1 reference
Timothy J Carrothers
1 reference
Patricia M LoRusso
1 reference
Yu-Waye Chu
1 reference
Ted Shih
1 reference
David Loecke
1 reference
Amita Joshi
1 reference
Ola Saad
1 reference
Joo-Hee Yi
1 reference
Sandhya Girish
1 reference
1 January 2013
1 reference
1 reference
2
1 reference
1
1 reference
11-24
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference